Gradual thrombocytopenia induced by long‐term trastuzumab exposure

E-ISSN： 1365-2710|41|5|563-565

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.41, Iss.5, 2016-10, pp. : 563-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COAGULATION DEFECTS INDUCED BY LONG‐TERM ANTICOAGULANT THERAPY*,†

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 8, Iss. 6, 1960-06 ,pp. : 419-430

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiotoxicity Related to Long‐Term Trastuzumab Therapy in Metastatic Breast Cancer: The Potential Role of Treatment Duration and Cardiac Risk Factors

THE BREAST JOURNAL, Vol. 21, Iss. 3, 2015-05 ,pp. : 318-321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long‐Term Extension of the BENEFIT Study

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 11, 2013-11 ,pp. : 2875-2883

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 11, 2013-11 ,pp. : 2884-2891

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Rhabdomyolysis in a Patient with Long‐Term Exposure to Intrathecal Ziconotide: A Case Report

PAIN PRACTICE, Vol. 15, Iss. 3, 2015-03 ,pp. : E34-E39

John Wiley & Sons Inc

Access to resources Recommend Favorite